En la enfermedad de Pringle-Bourneville, o esclerosis tuberosa, es frecuente la presencia de quistes renales múltiples, fibromas y angiomiolipomas (algunos. Bourneville disease. Patient with facial angiofibromas caused by tuberous A case of tuberous sclerosis showing facial angiofibromas in characteristic butterfly pattern. Specialty · Neurology, medical genetics. Tuberous sclerosis complex (TSC), is a rare multisystem genetic disease that causes .. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M. L’esclerosi tuberosa (ET), coneguda també amb els noms de síndrome de Bourneville Pringle, tuberoesclerosi o epiloia, és una malaltia pediàtrica i d’ origen.
|Published (Last):||19 May 2011|
|PDF File Size:||13.1 Mb|
|ePub File Size:||20.28 Mb|
|Price:||Free* [*Free Regsitration Required]|
Published studies are primarily clinical and epidemiological research but also basic. CiteScore measures average citations received per document published.
SRJ is a prestige metric based on the idea that not all citations are the same.
Tuberous sclerosis – Wikipedia
dw SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
Tuberous sclerosis, also called Bourneville Pringle disease, is a phakomatosis with potential dermal, nerve, kidney and lung damage. It is characterized by the development of benign proliferations in many organs, which result in different clinical manifestations.
It is associated with the mutation of two genes: MTOR activation signal has been recently described in systemic lupus erythematosus Vourneville-pringle and its inhibition could bourneville-pringlle beneficial in patients with lupus nephritis.
We report the case of a patient who began with clinical manifestations of tuberous sclerosis complex TSC 30 years after the onset of SLE with severe renal disease tipe IV nephritis who improved after treatment with iv pulses of cyclophosphamide.
We found only two similar cases in the literature, and hence considered the coexistence of these two entities of great interest.
Previous article Next article. July – August Pages Carmen Carrasco Cubero a.
This item has received. Summary of the Major Features of the Three Cases. Show more Show less.
MTOR activation signal has been recently described in systemic lupus erythematosus SLE and its oburneville-pringle could be beneficial in patients with lupus nephritis. We report the case of a patient who began with clinical manifestations of tuberous sclerosis complex TSC 30 years after the onset of SLE with severe renal oburneville-pringle tipe IV nephritis who improved after treatment with iv pulses of cyclophosphamide.
We found only two similar cases in the literature, and hence considered the coexistence of these two entities of great interest. Subscriber If you already have your login data, please click here. From Monday to Friday from enfermedaf a. Subscribe to our Newsletter. Clinical Practice Guidelines for the Treatment of Systemic Renal Transplantation in Systemic Lupus Erythematosus Si continua navegando, consideramos que acepta su uso. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
Are you a health professional able to prescribe or dispense drugs?